Diaceutics 

$2.00
10
+$0.00+0% Thursday 13:30

統計

當日最高
2
當日最低
2
52週高點
2
52週低點
1.3672
成交量
3,500
平均成交量
-
市值
169.63M
本益比
0
股息殖利率
-
股息
-

即將到來

財報

26May預期
Q1 2024
Q2 2024
Q4 2024
Q1 2025
Q2 2025
Q4 2025
Q1 2026
-3.65
-0.93
1.78
4.5
預期EPS
2.9534167136000002
實際EPS
2.9534167136000002

財務

-5.33%利潤率
未盈利
2019
2020
2021
2022
2023
2024
80.67M營收
-4.3M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 DIUXF 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Diaceutics PLC operates as a global diagnostic commercialization entity, providing pharmaceutical companies worldwide with essential data, sophisticated analytics, and implementation support. Central to its offerings is the DXRX platform, a comprehensive suite designed to address various aspects of precision medicine. This platform delivers: DXRX Data Solutions: Granting access to a vast network of laboratory diagnostic testing data. Key components here include DXRX Signal (for specific data insights), Lab Mapping, a Testing Dashboard, and Physician Mapping services. DXRX Marketplace Solutions: A crucial hub that fosters collaborations between laboratories, pharmaceutical firms, and diagnostic companies to advance precision medicine initiatives. DXRX Patient Journey: Enables pharmaceutical clients to conduct in-depth, longitudinal analyses of individual patient biomarker testing pathways. This insight is vital for pinpointing opportunities for earlier intervention and optimized treatment strategies. DXRX Lab Benchmarking: Empowers laboratories to enhance their competitive standing by comparing critical performance metrics – such as disease profiles, testing methodologies, market share, and turnaround times – against industry peers. DXRX Test Reimbursement: Facilitates pharmaceutical companies' engagement with laboratories to secure funding for the launch of novel companion diagnostics, thereby accelerating test adoption and market penetration. DXRX Test Signal: Provides real-time alerts regarding testing events, enabling pharmaceutical clients to quickly identify patients who may benefit from specific therapies. Beyond the DXRX platform, Diaceutics offers a range of supplementary services. These include strategic consulting for precision medicine diagnostics, as well as diagnostic landscape analysis, planning, implementation, and tracking. The company also provides support for test standardization, quality assessment, report optimization, laboratory technical assistance, test access and reimbursement solutions, comprehensive laboratory training, and educational resources. Established in 2005, Diaceutics PLC maintains its headquarters in Belfast, United Kingdom.
Show more...
執行長
Mr. Peter Keeling
員工
184
國家
愛爾蘭
ISIN
GB00BJQTGV64

上市

0 Comments

分享你的想法

FAQ

Diaceutics 今天的股價是多少?
DIUXF 目前價格為 $2.00 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Diaceutics 股價表現。
Diaceutics 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Diaceutics 的股票以代號 DIUXF 進行交易。
Diaceutics 的股價在上漲嗎?
DIUXF 股票較上週上漲 +0%,本月上漲 +19.76%,過去一年 Diaceutics 上漲 +46.28%。
Diaceutics 的市值是多少?
今天 Diaceutics 的市值為 169.63M
Diaceutics 下一次財報日期是什麼時候?
Diaceutics 將於 September 29, 2026 公布下一次財報。
Diaceutics 上一季度的財報如何?
DIUXF 上一季度的財報為每股 0.04 USD,預估為 0.04 USD,帶來 +0% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Diaceutics 去年的營收是多少?
Diaceutics 去年的營收為 80.67MUSD。
Diaceutics 去年的淨利是多少?
DIUXF 去年的淨收益為 -4.3MUSD。
Diaceutics 有多少名員工?
截至 June 11, 2026,公司共有 184 名員工。
Diaceutics 位於哪個產業?
Diaceutics從事於Health & Wellness產業。
Diaceutics 何時完成拆股?
Diaceutics 最近沒有進行任何拆股。
Diaceutics 的總部在哪裡?
Diaceutics 的總部位於 愛爾蘭 的 Belfast。